Myriad Genetics, Inc. (NASDAQ: MYGN) announced that it presented additional results of its completed Phase 2 follow-on study of Flurizan? in patients with mild Alzheimer’s disease at the annual meeting of the American Association for Geriatric Psychiatry (AAGP), held March 1-4, 2007 in New Orleans.
Because of adverse scarring prone to darker skinned patients, some African American women may choose not to have breast reduction. Instead, these women live with the daily pain and physical restraint caused by overly large breasts.
Rates of major depression are higher among whites, but the condition appears more likely to be severe, untreated and disabling among blacks, according to a report in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Electronic health records (EHRs) allow doctors to find the information they need to manage a patient’s care at the touch of a button. But several journal articles have reported errors related to EHR use.
A new digital ophthalmoscope, devised by a research team led by the University of Warwick, can provide both doctors and high street optometrists with a hand-held eye disease diagnosis device equal to the power of bulky hospital-based eye diagnosis cameras.
About one in four women older than 65 has been the victim of physical, sexual or psychological violence at the hands of a spouse or other intimate partner, according to a study done in two northwestern states.
A woman?s breast cancer diagnosis can wreak as much havoc on her emotions as it does on her physical health. Mothers who experience bouts of depression during their battles with breast cancer may find that the effects reach beyond their own psyches to those of their children.
Network for the Improvement of Addiction Treatment (NIATx) will host the first NIATx Summit in San Antonio. Addiction treatment providers, payers, policymakers and clinicians will come together to celebrate recent successes in treatment access and retention, unveil a national campaign and learn cutting-edge practices to improve the quality of treatment service.
A retrospective analysis of a large U.S. managed care database showed that patients who took Pfizer’s cholesterol-lowering medicine Lipitor? (atorvastatin calcium) Tablets had a significant 14 percent reduction in the risk of cardiovascular events, including heart attacks and strokes, compared with patients who took simvastatin.
A study demonstrates that a new technique safely and effectively removes blood clots in the body faster, reducing patient risk for pulmonary embolism and disability.